Identification of immunogenic HLA-A*02:01 epitopes associated with HCC for immunotherapy development
These results highlight the potential of these peptides to be considered as targets for immunotherapies. The discovery of such immunogenic epitopes should improve immune-based treatments for liver cancer in combination with the current treatment approach.
Authors
- Joël Plumas (ORCID: https://orcid.org/0000-0002-5005-4301)
- Anthony Maino (ORCID: https://orcid.org/0009-0000-1012-8292)
- Laurence Chaperot (ORCID: https://orcid.org/0000-0002-1479-9410)
- Ekaterina Bourova-Flin (ORCID: https://orcid.org/0000-0002-5673-9045)
- Zuzana Macek Jílková (ORCID: https://orcid.org/0000-0002-2553-5971)
- Thomas Decaens (ORCID: https://orcid.org/0000-0003-0928-0048)
- Philippe Saas (ORCID: https://orcid.org/0000-0002-8857-9939)
- Olivier Manches (ORCID: https://orcid.org/0000-0003-4509-2941)
- Sophie Rousseaux (ORCID: https://orcid.org/0000-0001-5246-5350)
- Saadi Khochbin (ORCID: https://orcid.org/0000-0002-0455-0857)
Institutions
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Centre Hospitalier Universitaire de Grenoble (FR)
- Université Grenoble Alpes (FR)
Publication Details
- Journal
- Hepatology Communications
- Published
- 2025-02-26
- DOI
- https://doi.org/10.1097/hc9.0000000000000659
- Citations
- 3
- Primary Topic
- Immunotherapy and Immune Responses
- Type
- article
- Field-Weighted Citation Impact
- 2.39